Showing results (81-90 of 93) with videos related to
Sort By:
Pageof 10
Cells|June 25, 2020
The Anti-Inflammatory and Pain-Relieving Effects of AR170, an Adenosine A3 Receptor Agonist, in a Rat Model of ColitisLuca Antonioli, Elena Lucarini, Catia Lambertucci, et al.The Journal of Pharmacy and Pharmacology|April 29, 2014
Pharmacological postconditioning of the rabbit heart with non-selective, A1 , A2A and A3 adenosine receptor agonistsSophia-Iris Bibli, Efstathios K Iliodromitis, Catia Lambertucci, et al.European Journal of Medicinal Chemistry|October 11, 2016
Imidazo[1,2-a]pyrazin-8-amine core for the design of new adenosine receptor antagonists: Structural exploration to target the A3 and A2A subtypesDaniela Poli, Matteo Falsini, Flavia Varano, et al.Journal of Medicinal Chemistry|August 28, 2019
Antioxidant-Conjugated 1,2,4-Triazolo[4,3-a]pyrazin-3-one Derivatives: Highly Potent and Selective Human A2A Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic PainMatteo Falsini, Daniela Catarzi, Flavia Varano, et al.Molecules (Basel, Switzerland)|April 23, 2022
A2A Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable?Andrea Spinaci, Catia Lambertucci, Michela Buccioni, et al.Journal of Medicinal Chemistry|July 16, 2019
Modifications on the Amino-3,5-dicyanopyridine Core To Obtain Multifaceted Adenosine Receptor Ligands with Antineuropathic ActivityMarco Betti, Daniela Catarzi, Flavia Varano, et al.Chemmedchem|March 19, 2016
A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline NucleusValerio Mammoli, Alessandro Bonifazi, Diego Dal Ben, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 12, 2026
Synthesis and characterization of new P2X7 receptor antagonists as antitumor agentsMarianna Grignolo, Andrea Spinaci, Ludovica Ricci, et al.Pharmaceuticals (Basel, Switzerland)|June 1, 2023
"Dual Anta-Inhibitors" of the A2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling StudiesAndrea Spinaci, Michela Buccioni, Daniela Catarzi, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 12, 2025
A2A receptor antagonist 4-(2-((6-Amino-9-ethyl-8-(furan-2-yl)-9H-purin-2-yl)amino)ethyl)phenol, a promising adenosine derivative for glioblastoma treatmentAkshaya Murugesan, Aleksei Smirnov, Anxo Vila Alonso, et al.Pageof 10